Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM - Jan 7, 2016

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

PVLee

Rank: Mail Room [?]

Points: 183 [?]

Votes: 1 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - Jan 7, 2016 - Details

in response to

AGM - Jan 7, 2016 - Details

masila

posted on Jan 14, 2016 10:25AM

Masila, re: "The trials will start this quarter." Did Don confirm whether that means by the end of January or end of April? Toinv, re: "earliest payouts...would be in three years." ...possibly sooner. Why do you think it will take six? Thanks in advance, PVLee

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply